Alzheimers disease dementia as the diagnosis best supported by the cerebrospinal fluid biomarkers: Difference in cut-off levels from Thai experience

Objectives. To determine how beta-amyloid 1-42 (Aβ 1-42), total tau (tTau), and phosphorylated tau (pTau) levels in CSF behave in a cohort of Thai patients from the Memory Clinic in Bangkok, Thailand. Methods. During 20092011, twenty eight subjects from the memory clinic at Siriraj Hospital had CSF...

Full description

Saved in:
Bibliographic Details
Main Authors: V. Senanarong, N. Siwasariyanon, L. Washirutmangkur, N. Poungvarin, C. Ratanabunakit, N. Aoonkaew, S. Udomphanthurak
Other Authors: Mahidol University
Format: Article
Published: 2018
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/13634
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University
id th-mahidol.13634
record_format dspace
spelling th-mahidol.136342018-06-11T12:21:11Z Alzheimers disease dementia as the diagnosis best supported by the cerebrospinal fluid biomarkers: Difference in cut-off levels from Thai experience V. Senanarong N. Siwasariyanon L. Washirutmangkur N. Poungvarin C. Ratanabunakit N. Aoonkaew S. Udomphanthurak Mahidol University Biochemistry, Genetics and Molecular Biology Medicine Neuroscience Objectives. To determine how beta-amyloid 1-42 (Aβ 1-42), total tau (tTau), and phosphorylated tau (pTau) levels in CSF behave in a cohort of Thai patients from the Memory Clinic in Bangkok, Thailand. Methods. During 20092011, twenty eight subjects from the memory clinic at Siriraj Hospital had CSF analysis for AD biomarkers. Aβ 1-42, tTau, and pTau (at amino acid 181) were measured in CSF by ELISA technique. Results. Mean of Thai mental state examination (TMSE) of 28 Thai cohort was 16.48 (6.63). Fourteen had AD, ten had non-AD dementia, and four non-cases were those with subjective memory complaint (SMC) without dementia. Mean CSF Aβ 1-42, tTau, ptau (181), and pTau/Aβ 1-42 in the AD group were 241.36 (60.14)pg/mL, 222.79 (212.24)pg/mL, 40.79 (27.84)pg/mL, and 0.18 (0.12) accordingly. Mean CSF Aβ 1-42, tTau, pTau (181), and pTau/Aβ 1-42 in the non-AD dementia group were 430.40 (125.18)pg/mL, 349.30 (692.16)pg/mL, 36.80 (14.90)pg/mL, and 0.09 (0.04) accordingly. Mean CSF Aβ 1-42, tTau, pTau (181), and pTau/Aβ 1-42 in the non-cases with SMC without dementia were 499.75 (93.44)pg/mL, 137.25 (62.74)pg/mL, 31.75 (17.48)pg/mL, and 0.06 (0.02). There is significant difference (P 0.05) among the 3 groups in CSF Aβ 1-42 and pTau/Aβ 1-42. We propose mean + 1.5 SD of CSF Aβ 1-42 in AD group (331.57pg/mL) to be the cut-off point in Thai subjects. Conclusion. There are significant different in CSF Aβ 1-42 and CSF p-tau/A 1-42 among those with AD, non-AD dementia and non cases with SMC without dementia in Thai cohort. Cut-off point of CSF Aβ 1-42 of 331.57pg/mL is suggested in Thai study. © 2012 V. Senanarong et al. 2018-06-11T04:34:28Z 2018-06-11T04:34:28Z 2012-08-17 Article International Journal of Alzheimer's Disease. (2012) 10.1155/2012/212063 20900252 2-s2.0-84864923986 https://repository.li.mahidol.ac.th/handle/123456789/13634 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84864923986&origin=inward
institution Mahidol University
building Mahidol University Library
continent Asia
country Thailand
Thailand
content_provider Mahidol University Library
collection Mahidol University Institutional Repository
topic Biochemistry, Genetics and Molecular Biology
Medicine
Neuroscience
spellingShingle Biochemistry, Genetics and Molecular Biology
Medicine
Neuroscience
V. Senanarong
N. Siwasariyanon
L. Washirutmangkur
N. Poungvarin
C. Ratanabunakit
N. Aoonkaew
S. Udomphanthurak
Alzheimers disease dementia as the diagnosis best supported by the cerebrospinal fluid biomarkers: Difference in cut-off levels from Thai experience
description Objectives. To determine how beta-amyloid 1-42 (Aβ 1-42), total tau (tTau), and phosphorylated tau (pTau) levels in CSF behave in a cohort of Thai patients from the Memory Clinic in Bangkok, Thailand. Methods. During 20092011, twenty eight subjects from the memory clinic at Siriraj Hospital had CSF analysis for AD biomarkers. Aβ 1-42, tTau, and pTau (at amino acid 181) were measured in CSF by ELISA technique. Results. Mean of Thai mental state examination (TMSE) of 28 Thai cohort was 16.48 (6.63). Fourteen had AD, ten had non-AD dementia, and four non-cases were those with subjective memory complaint (SMC) without dementia. Mean CSF Aβ 1-42, tTau, ptau (181), and pTau/Aβ 1-42 in the AD group were 241.36 (60.14)pg/mL, 222.79 (212.24)pg/mL, 40.79 (27.84)pg/mL, and 0.18 (0.12) accordingly. Mean CSF Aβ 1-42, tTau, pTau (181), and pTau/Aβ 1-42 in the non-AD dementia group were 430.40 (125.18)pg/mL, 349.30 (692.16)pg/mL, 36.80 (14.90)pg/mL, and 0.09 (0.04) accordingly. Mean CSF Aβ 1-42, tTau, pTau (181), and pTau/Aβ 1-42 in the non-cases with SMC without dementia were 499.75 (93.44)pg/mL, 137.25 (62.74)pg/mL, 31.75 (17.48)pg/mL, and 0.06 (0.02). There is significant difference (P 0.05) among the 3 groups in CSF Aβ 1-42 and pTau/Aβ 1-42. We propose mean + 1.5 SD of CSF Aβ 1-42 in AD group (331.57pg/mL) to be the cut-off point in Thai subjects. Conclusion. There are significant different in CSF Aβ 1-42 and CSF p-tau/A 1-42 among those with AD, non-AD dementia and non cases with SMC without dementia in Thai cohort. Cut-off point of CSF Aβ 1-42 of 331.57pg/mL is suggested in Thai study. © 2012 V. Senanarong et al.
author2 Mahidol University
author_facet Mahidol University
V. Senanarong
N. Siwasariyanon
L. Washirutmangkur
N. Poungvarin
C. Ratanabunakit
N. Aoonkaew
S. Udomphanthurak
format Article
author V. Senanarong
N. Siwasariyanon
L. Washirutmangkur
N. Poungvarin
C. Ratanabunakit
N. Aoonkaew
S. Udomphanthurak
author_sort V. Senanarong
title Alzheimers disease dementia as the diagnosis best supported by the cerebrospinal fluid biomarkers: Difference in cut-off levels from Thai experience
title_short Alzheimers disease dementia as the diagnosis best supported by the cerebrospinal fluid biomarkers: Difference in cut-off levels from Thai experience
title_full Alzheimers disease dementia as the diagnosis best supported by the cerebrospinal fluid biomarkers: Difference in cut-off levels from Thai experience
title_fullStr Alzheimers disease dementia as the diagnosis best supported by the cerebrospinal fluid biomarkers: Difference in cut-off levels from Thai experience
title_full_unstemmed Alzheimers disease dementia as the diagnosis best supported by the cerebrospinal fluid biomarkers: Difference in cut-off levels from Thai experience
title_sort alzheimers disease dementia as the diagnosis best supported by the cerebrospinal fluid biomarkers: difference in cut-off levels from thai experience
publishDate 2018
url https://repository.li.mahidol.ac.th/handle/123456789/13634
_version_ 1763490188379553792